PFGIA
VIRX

Patriot Financial Group Insurance Agency’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5
Closed – – 2026
2020
Q3 		$0 Hold
5
– – ﹤0.01% 1881
2020
Q2 		$0 Hold
5
– – ﹤0.01% 1872
2020
Q1 		$0 Sell
5
-2
-29% -$43 ﹤0.01% 1775
2019
Q4 		$0 Hold
7
– – ﹤0.01% 1476
2019
Q3 		$0 Hold
7
– – ﹤0.01% 1497
2019
Q2 		$1K Buy
7
+2
+40% +$77 ﹤0.01% 1378
2019
Q1 		$0 Buy
+5
New +$113 ﹤0.01% 1331

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Patriot Financial Group Insurance Agency's VIRX Position: Q4 2020 in Review

Patriot Financial Group Insurance Agency sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q4 2020, closing a stake of 5 shares.

Patriot Financial Group Insurance Agency first reported a position in VIRX in Q1 2019 and held it in 7 quarters. The position peaked at $1K in Q2 2019. 33 funds tracked by Wall St. Rank hold VIRX as of Q4 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 5 Viracta Therapeutics, Inc. Common Stock shares in Q4 2020.
  • Patriot Financial Group Insurance Agency first reported a position in Viracta Therapeutics, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
  • Patriot Financial Group Insurance Agency's Viracta Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2019.
  • 33 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2020, filed 15 Jan 2021.